Kaike Life Sciences Receives China NMPA Registration Certificate for Guidewires DS-275 and DS-330
Kokai Life Sciences
Developer, Manufacturer, and Distributor in the Field of Structural Heart Disease
Click the blue words to follow us
On January 22, 2026, Kokai (Nantong) Life Sciences Co., Ltd. independently developedGuidewire (DS-275、DS-330)Officially Obtained Medical Device Registration Certificate of the People's Republic of China! Kokai Life Sciences, dedicated to the cardiovascular intervention field, adds another innovative achievement with cutting-edge technology to support clinical diagnosis and treatment, safeguarding the cardiovascular health of the Chinese people!
Guidewire Diagram
DS-330
DS-275
Guidewires are suitable for guiding the insertion and positioning of interventional devices such as catheters into blood vessels, but are not intended for transseptal placement of various cardiovascular catheters into the left heart.
About Kokai
Kokai (Nantong) Life Sciences Co., Ltd. was established in September 2018. It is a high-end biopharmaceutical technology enterprise that integrates the research, development, production, and sales of medical devices in the field of structural heart disease. The company develops systematic solutions for valve diseases targeting different populations, needs, and scenarios. Its technical team is primarily composed of R&D personnel who have returned from the United States and Germany and possess extensive experience in the development and research of cardiac medical technologies. The company’s technical level is leading in China and is synchronized with cutting-edge cardiac medical treatment technologies worldwide.
The company has been honored with:
2024 Hurun Global Cheetah Companies List
2024 Hurun China Healthcare Rising Enterprises
2023 Hurun Global Gazelle Companies List
Top 100 Emerging Medical Device Companies in China 2023
2023 Future Healthcare 100 Strong List "Top 100 China Innovative Medical Devices"
2022 Annual Outstanding Contribution to Scientific Innovation in the Northern High-Tech Zone of the City - Innovation Star
2022 KPMG China's Second Biotech Innovation 50
2022 China Investment Healthcare VENTURE50 List